MTOR and colorectal cancer: The median TTF of FBXW7-positive colorectal cancer patients was 3.3 months (1.4–4.4) on mTOR inhibitors versus 1.8 months (0.6–4.9) for FBXW7-negative patients with colorectal cancer (p = 0.27).